Page last updated: 2024-11-05

cyanamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cyanamide, also known as carbodiimide, is a colorless, crystalline solid with the formula CH2N2. It is a highly versatile compound used in various industrial applications, including the production of fertilizers, pharmaceuticals, and polymers.

Cyanamide is synthesized by the reaction of calcium cyanamide with water or acids. It can also be produced by the direct reaction of ammonia with carbon monoxide at high temperatures and pressures.

Cyanamide is a strong base and a good nucleophile. It readily reacts with acids and alcohols to form salts and esters, respectively. Cyanamide can also be used as a crosslinking agent for polymers and as a catalyst for various organic reactions.

Cyanamide is a potent inhibitor of mitochondrial respiration and has been shown to have neurotoxic effects. It is also a known teratogen, meaning it can cause birth defects. Due to its toxicity, cyanamide is handled with care in industrial settings.

Cyanamide is studied for its potential applications in agriculture, medicine, and materials science. For instance, it is used as a fertilizer to improve soil fertility, and it is being investigated as a potential treatment for various diseases, such as cancer and Alzheimer's disease.

Overall, cyanamide is a complex compound with a wide range of applications and potential benefits. However, it is also a toxic substance that must be handled with caution.'

Cyanamide: A cyanide compound which has been used as a fertilizer, defoliant and in many manufacturing processes. It often occurs as the calcium salt, sometimes also referred to as cyanamide. The citrated calcium salt is used in the treatment of alcoholism. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

cyanamide : A nitrile that is hydrogen cyanide in which the hydrogen has been replaced by an amino group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9864
CHEMBL ID56279
CHEBI ID16698
MeSH IDM0005434

Synonyms (70)

Synonym
AKOS009031491
2669-76-3
h2n-c#n
CHEBI:16698 ,
nh2cn
h2ncn
cyanogen nitride
cyanogenamide
nsc-24133
wln: zcn
n-cyanoamine
hydrogen cyanamide
usaf ek-1995
cyanoamine
amidocyanogen
carbamonitrile
nsc24133
carbodiamide
dormex
einecs 206-992-3
nsc 24133
cyanamide [jan]
alzogur
hsdb 1550
tsaks
brn 1732569
caswell no. 485a
epa pesticide chemical code 014002
cyanamide (jp17)
cyanamide (tn)
D00123
nsc-267195
nsc267195
420-04-2
cyanamide
C01566
DB02679
cyanamide, 99%
NCGC00164378-01
NCGC00164378-02
CHEMBL56279
BMSE000656
FT-0665242
NCGC00164378-03
unii-21cp7826lc
ec 206-992-3
4-03-00-00145 (beilstein handbook reference)
deurbraak
21cp7826lc ,
NCGC00254586-01
tox21_112109
dtxcid7014490
cas-420-04-2
dtxsid9034490 ,
tox21_300678
STL281853
FT-0624124
cyanamide [mi]
cyanamide [who-dd]
cyanamide [hsdb]
BBL027645
cyanamine
ch2n2
F8881-3984
mfcd00007572
cyanamide aq
Q414555
aminoformonitrile, 50% aqueous solution
AMY6233
EN300-19848

Research Excerpts

Overview

Cyanamide is a multifunctional agrochemical used as a pesticide, herbicide, and fertilizer. It is a potent inhibitor of aldehyde dehydrogenase (ALDH: EC 1.2.1.3) used in the treatment of alcoholics.

ExcerptReferenceRelevance
"Cyanamide is a known alcohol deterrent, and it may cause severe cyanamide-ethanol reaction if a patient consumes high amounts of alcohol during treatment. "( [Cyanamide-ethanol reaction induced shock: report of a case and literature review].
Fuke, C; Higa, A; Kondo, Y; Kukita, I, 2013
)
2.74
"Cyanamide (CA) is a phytotoxic compound produced by four Fabaceae species: hairy vetch, bird vetch, purple vetch and black locust. "( Phytotoxic cyanamide affects maize (Zea mays) root growth and root tip function: from structure to gene expression.
Bogatek, R; Gniazdowska, A; Kurek, W; Rudzińska-Langwald, A; Sliwinska, E; Soltys, D; Szajko, K, 2014
)
2.23
"Cyanamide is an allelochemical produced by hairy vetch (Vicia villosa Roth.). "( Cyanamide mode of action during inhibition of onion (Allium cepa L.) root growth involves disturbances in cell division and cytoskeleton formation.
Bogatek, R; Gniazdowska, A; Kurek, W; Rudzińska-Langwald, A; Sliwinska, E; Soltys, D, 2011
)
3.25
"Cyanamide seems to be an effective and well tolerated pharmacological adjunct to psychosocial and behavioural treatment programmes for the treatment of some adolescent alcohol-dependent patients. "( Comparison of cyanamide and placebo in the treatment of alcohol dependence of adolescents.
Mair, A; Niederhofer, H; Staffen, W,
)
1.93
"Cyanamide (NH2CN) is a molecule of interstellar interest which can be implied in prebiotic chemistry. "( Experimental study of water-ice catalyzed thermal isomerization of cyanamide into carbodiimide: implication for prebiotic chemistry.
Aycard, JP; Borget, F; Chiavassa, T; Duvernay, F, 2004
)
2
"Cyanamide is a multifunctional agrochemical used, for example, as a pesticide, herbicide, and fertilizer. "( Direct quantitative determination of cyanamide by stable isotope dilution gas chromatography-mass spectrometry.
Fujii, Y; Hiradate, S; Kamo, T; Kato, K; Nakajima, E, 2005
)
2.04
"Cyanamide is a chemical substance used in the treatment of chronic alcoholism as well in agriculture as a fertilizer. "( Allergic contact dermatitis with a fertilizer containing hydrogen cyanamide (Dormex).
Angelini, G; Bonamonte, D; Conserva, A; Foti, C; Pepe, ML; Soleo, L, 2008
)
2.03
"Cyanamide is a potent inhibitor of aldehyde dehydrogenase (ALDH: EC 1.2.1.3) used in the treatment of alcoholics. "( Acetaldehyde, a metabolite of ethanol, activates the hypothalamic-pituitary-adrenal axis in the rat.
Ameno, K; Coventry, TL; Finn, DP; Harbuz, MS; Jessop, DS; Jiri, I; Kinoshita, H; Roberts, DJ,
)
1.57
"Cyanamide is a drug frequently used as aversion therapy in chronic alcoholism. "( Cyanamide and its calcium form: do they differ with respect to their action on the liver cell? Experimental study in the rat.
Valérdiz, S; Vázquez, JJ, 1989
)
3.16

Effects

Cyanamides (NCN) have been shown to have a larger transition dipole strength than cyano-probes. Like cyanamide it has a rapid onset of action in vivo with the highest inhibition occurring after 2--24 hrs. Cyanamide (CA) has been reported as a natural compound produced by hairy vetch.

ExcerptReferenceRelevance
"Like cyanamide it has a rapid onset of action in vivo with the highest inhibition occurring after 2--24 hrs."( A comparative study on the effects of disulfiram, cyanamide and 1-aminocyclopropanol on the acetaldehyde metabolism in rats.
Marchner, H; Tottmar, O, 1978
)
0.97
"Cyanamides (NCN) have been shown to have a larger transition dipole strength than cyano-probes. "( 2D-IR studies of cyanamides (NCN) as spectroscopic reporters of dynamics in biomolecules: Uncovering the origin of mysterious peaks.
Adeyiga, O; Brewer, SH; Chalyavi, F; Fenlon, EE; Monzy, JN; Nguyen, JK; Odoh, SO; Schmitz, AJ; Tucker, MJ; Weiner, JM, 2020
)
2.34
"Cyanamide has been used for decades for medical intentions in the treatment of alcoholism and for agricultural purposes as a plant growth regulator and bud-breaking agent. "( Cyanamide-mediated Inhibition of N-acetyltransferase 1.
Blömeke, B; Bonifas, J; Dierolf, D; Scheitza, S, 2012
)
3.26
"Cyanamide (CA) has been reported as a natural compound produced by hairy vetch (Vicia villosa Roth.) and it was shown also to be an allelochemical, responsible for strong allelopathic potential in this species. "( Inhibition of tomato (Solanum lycopersicum L.) root growth by cyanamide is due to altered cell division, phytohormone balance and expansin gene expression.
Bogatek, R; Gniazdowska, A; Rudzińska-Langwald, A; Soltys, D; Wiśniewska, A, 2012
)
2.06
"Cyanamide (NH(2)CN) has recently been isolated as a plant growth inhibitor from Vicia villosa, which is the first discovery of cyanamide from natural sources. "( Evidence of cyanamide production in hairy vetch Vicia villosa.
Fujii, Y; Hiradate, S; Hirota, M; Kamo, T; Kato, K; Nakajima, E, 2006
)
2.16
"Cyanamide (NH2CN) has recently been proven to be a natural product, although it has been synthesized for over 100 years for agricultural and industrial purposes. "( Limited distribution of natural cyanamide in higher plants: occurrence in Vicia villosa subsp. varia, V. cracca, and Robinia pseudo-acacia.
Endo, M; Fujii, Y; Hiradate, S; Hirai, N; Hirota, M; Kamo, T; Kasahara, R; Sato, M; Yamaya, H, 2008
)
2.07
"Like cyanamide it has a rapid onset of action in vivo with the highest inhibition occurring after 2--24 hrs."( A comparative study on the effects of disulfiram, cyanamide and 1-aminocyclopropanol on the acetaldehyde metabolism in rats.
Marchner, H; Tottmar, O, 1978
)
0.97

Actions

ExcerptReferenceRelevance
"Cyanamide was shown to inhibit the catalase activity in vitro in a dose-related manner."( Studies on ethanol-brain catalase interaction: evidence for central ethanol oxidation.
Amit, Z; Aragon, CM; Stotland, LM, 1991
)
1

Treatment

Cyanamide-treated plants exhibited oxidative stress. The cyanamide pretreatment (25 mg/kg) significantly increased the mortality of rats given 6.5 to 7.0 g/kg ethanol and decreased the LD50 of ethanol from 7.3 to 5.9g/kg.

ExcerptReferenceRelevance
"Cyanamide-treated plants exhibited oxidative stress (i.e."( Cyanamide phytotoxicity in soybean (Glycine max) seedlings involves aldehyde dehydrogenase inhibition and oxidative stress.
Fujii, Y; Maninang, JS; Okazaki, S, 2015
)
2.58
"Cyanamide pretreatments significantly potentiated ethanol- but not acetaldehyde-induced CTA."( Role of acetaldehyde in ethanol-induced conditioned taste aversion in rats.
De Witte, P; Escarabajal, MD; Quertemont, E, 2003
)
1.04
"Cyanamide + ethanol treatment also reduced k(s) in the brain stem (66%, P <.001), cortex (59%, P <.001), and cerebellum (55%, P <.001)."( Acute exposure to the nutritional toxin alcohol reduces brain protein synthesis in vivo.
Bonner, AB; Dalwai, S; Marway, JS; Preedy, VR, 2003
)
1.04
"The cyanamide pretreatment (25 mg/kg) significantly increased the mortality of rats given 6.5 to 7.0 g/kg ethanol and decreased the LD50 of ethanol from 7.3 to 5.9 g/kg."( Potentiation of ethanol toxicity by cyanamide in relation to acetaldehyde accumulation.
Hillbom, ME; Lindros, KO; Sarviharju, MS, 1983
)
1.02
"The cyanamide treatment caused a transient (3--4 day) decrease in the ethanol intake, after which the consumption increased to 3.7 +/- 2.9 g/kg/day."( Evidence against a biphasic effect of acetaldehyde on voluntary ethanol consumption in rats.
Deitrich, RA; Eriksson, CJ, 1980
)
0.74
"The cyanamide-pretreatment group (CY), in which an extremely high acetaldehyde concentration developed, in comparison with the control and pyrazole-pretreated (PY) groups, showed a gradual increase of portal blood ethanol, a 25% reduction in the amount of absorbed ethanol, and an 85% smaller absorption rate constant value (Ka)."( A comparative study of ethanol absorption in the canine jejunum after pretreatment with cyanamide or pyrazole.
Ameno, K; Ameno, S; Fuke, C; Ijiri, I; Shinohara, T, 1993
)
0.99
"Cyanamide pretreatment abolished the concentration dependence."( The effect of inhibition of aldehyde dehydrogenase on nasal uptake of inspired acetaldehyde.
Morris, JB; Stanek, JJ, 1999
)
1.02
"Cyanamide pre-treatment had no effect on nitrophenol hydroxylase, 7-methoxy-, 7-ethoxy- or 7-benzyloxyresorufin O-dealkylase activities in 24 h cultures from untreated rats, and had no effect on intracellular glutathione content in cultures from untreated rats, or in cultures from isoniazid-treated rats in which cytochrome P4502E1 (CYP2E1) is increased."( Effect of cyanamide on toxicity and glutathione depletion in rat hepatocyte cultures: differences between two dichloropropanol isomers.
Fry, JR; Hammond, AH, 1999
)
1.43
"When cyanamide-treated alcoholics relapse drinking, the combined effect of cyanamide and alcohol produce more severe portal inflammation along with the emergence of ground-glass inclusions."( Comparison of cyanamide and disulfiram in effects on liver function.
Ishii, H; Maruyama, K; Okuyama, K; Suzuki, Y; Takahashi, H; Tamai, H; Yokoyama, A, 2000
)
1.12
"When cyanamide-treated alcoholics relapse into drinking, more severe inflammation develops in the liver."( Cyanamide-induced liver dysfunction after abstinence in alcoholics: a long-term follow-up study on four cases.
Ishii, H; Maruyama, K; Nakano, M; Okuyama, K; Suzuki, Y; Takahashi, H; Tamai, H; Yokoyama, A, 2000
)
2.2
"In cyanamide-pretreated RBCs, the molar ratios of acetaldehyde bound to hemoglobin ranged from 0.0013 after 3 hours of exposure to 20 nmol/ml [14C]acetaldehyde up to 0.039 after 48 hours of exposure to 200 nmol/ml [14C]acetaldehyde."( The formation of stable acetaldehyde-hemoglobin adducts in a red blood cell model.
Belcher, JD; DeMaster, EG; Gapstur, SM; Gross, MD; Potter, JD,
)
0.65
"In cyanamide-treated rats, the elimination of ethanol was slow but the rates in the oxidoreduction were high, indicating more complete rate-limitation by the oxidation of acetaldehyde."( Hydrogen transfer between ethanol molecules during oxidoreduction in vivo.
Cronholm, T, 1985
)
0.78
"Pretreatment with cyanamide, an inhibitor of aldehyde dehydrogenase, did not attenuate the ethanol-induced decrease in phosphorylation S6k1(Thr(389)), but partially prevented the ethanol-induced lowering of 4EBP1 phosphorylation."( Differential phosphorylation of translation initiation regulators 4EBP1, S6k1, and Erk 1/2 following inhibition of alcohol metabolism in mouse heart.
Lang, CH; Vary, TC, 2008
)
0.67
"Pretreatment with cyanamide increased hepatic acetaldehyde levels 5-fold, yet this was associated with a decrease in lipid peroxidation, indicating that acetaldehyde is not the xanthine oxidase substrate involved."( Role of xanthine oxidase in ethanol-induced lipid peroxidation in rats.
Alderman, J; Inatomi, N; Kato, S; Kawase, T; Lieber, CS, 1990
)
0.6

Toxicity

ExcerptReferenceRelevance
" These results suggest that dibromoalkane-induced cell lysis is due to lipid peroxidation as well as cytochrome P450-dependent formation of toxic bromoaldehydic metabolites which can bind with cellular macromolecules."( Molecular mechanisms of dibromoalkane cytotoxicity in isolated rat hepatocytes.
Khan, S; O'Brien, PJ; Sood, C, 1993
)
0.29
" In cultures from untreated animals the primary alcohol, 2,3-dichloropropanol, was not toxic and did not significantly deplete glutathione."( Effect of cyanamide on toxicity and glutathione depletion in rat hepatocyte cultures: differences between two dichloropropanol isomers.
Fry, JR; Hammond, AH, 1999
)
0.71
" The predominant toxic effects were nausea and vomiting (29%), headache (22%), contact dermatitis (19%), and erythema (18%)."( The adverse effects of hydrogen cyanamide on human health: an evaluation of inquiries to the New Zealand National Poisons Centre.
Beasley, M; Schep, L; Temple, W, 2009
)
0.64
" These results indicate that acetaldehyde is generated as a by-product during steroidogenesis and can exert toxic effects to impair the differentiation of granulosa cells, reduce ovulation and decrease oocyte quality."( Endogenous acetaldehyde toxicity during antral follicular development in the mouse ovary.
Fujita, Y; Ikeda, C; Kawai, T; Kawashima, I; Mihara, T; Negishi, H; Richards, JS; Shimada, M, 2012
)
0.38

Pharmacokinetics

A pharmacokinetic and dynamic study of cyanamide, an inhibitor of aldehyde dehydrogenase (ALDH), has been carried out in man after oral administrations.

ExcerptReferenceRelevance
"A pharmacokinetic and dynamic study of cyanamide, an inhibitor of aldehyde dehydrogenase (ALDH) used as an adjuvant in the aversive therapy of chronic alcoholism, has been carried out in man after oral administrations."( Lack of correlation between pharmacokinetic and pharmacodynamic behaviour of cyanamide in man. A preliminary report.
Colom, H; Domenech, J; Izquierdo, I; Obach, R; Peraire, C; Pruñonosa, J; Torrent, J, 1991
)
0.78
"A pharmacokinetic study of carbimide, an inhibitor of aldehyde dehydrogenase, used as an adjuvant in the aversive therapy of chronic alcoholism, has been carried out in male human volunteers for intravenous and oral administration."( Pharmacokinetics and oral bioavailability of carbimide in man.
Colom, H; Domenech, J; Obach, R; Peraire, C; Pruñonosa, J; Torrent, J,
)
0.13
"A pharmacokinetic study of cyanamide, an inhibitor of aldehyde dehydrogenase (E."( Pharmacokinetics of cyanamide in dog and rat.
Arso, J; Colom, H; Obach, R; Peraire, C; Pruñonosa, J, 1989
)
0.9
" We examined the pharmacokinetic mechanism of the inhibition of ethanol metabolism by cyanamide, an inhibitor of mitochondrial aldehyde dehydrogenase."( Noncompetitive-like inhibition of ethanol elimination by cyanamide treatment: pharmacokinetic study.
Fujimiya, T; Komura, S; Li, YJ; Ohbora, Y; Uemura, K, 1996
)
0.76

Bioavailability

Food does not appear to modify the absolute bioavailability of cyanamide. The cyanamide-pretreatment group (CY), in which an extremely high acetaldehyde concentration developed, showed a gradual increase of portal blood ethanol.

ExcerptReferenceRelevance
" administration of 1 mg/kg was performed in order to determine the absolute bioavailability and the main pharmacokinetic parameters."( Lack of correlation between pharmacokinetic and pharmacodynamic behaviour of cyanamide in man. A preliminary report.
Colom, H; Domenech, J; Izquierdo, I; Obach, R; Peraire, C; Pruñonosa, J; Torrent, J, 1991
)
0.51
" Peak plasma concentrations, after oral administration of 4 mg kg-1 were achieved at 30 min and oral bioavailability was about 65%."( Pharmacokinetics of cyanamide in dog and rat.
Arso, J; Colom, H; Obach, R; Peraire, C; Pruñonosa, J, 1989
)
0.6
" Food does not appear to modify the absolute bioavailability of cyanamide (F = 93."( Bioavailability of cyanamide in fasted and unfasted rats.
Domenech, J; Obach, R; Valenti, C; Valles, J; Valles, JM,
)
0.7
" The cyanamide-pretreatment group (CY), in which an extremely high acetaldehyde concentration developed, in comparison with the control and pyrazole-pretreated (PY) groups, showed a gradual increase of portal blood ethanol, a 25% reduction in the amount of absorbed ethanol, and an 85% smaller absorption rate constant value (Ka)."( A comparative study of ethanol absorption in the canine jejunum after pretreatment with cyanamide or pyrazole.
Ameno, K; Ameno, S; Fuke, C; Ijiri, I; Shinohara, T, 1993
)
1.02
" The value of the absorption rate constant in the cyanamide-pretreated group with high acetaldehyde levels was the lowest among the four groups, but there were no significant differences among the remaining groups."( Additional proof of reduction of ethanol absorption from rat intestine in vivo by high acetaldehyde concentrations.
Ameno, K; Ameno, S; Fuke, C; Ijiri, I; Kinoshita, H, 1995
)
0.54
" H2O2 of low concentration reduced the absorption rate of Ca2+, and at high concentration, it changed the Ca2+ transport direction from absorption to release."( [Relationships between H2O2 metabolism and Ca2+ transport in dormancy-breaking process of nectarine floral buds].
Gao, DS; Li, L; Liu, QZ; Tan, Y; Wang, JW; Wei, HR, 2015
)
0.42
"The ATP-binding cassette transporter P-glycoprotein (P-gp) is known to limit both brain penetration and oral bioavailability of many chemotherapy drugs."( A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
Ambudkar, SV; Brimacombe, KR; Chen, L; Gottesman, MM; Guha, R; Hall, MD; Klumpp-Thomas, C; Lee, OW; Lee, TD; Lusvarghi, S; Robey, RW; Shen, M; Tebase, BG, 2019
)
0.51

Dosage Studied

Cyanamide is found in the human body. It is used to make calcium cyanamide, a form of calcium phosphate.

ExcerptRelevanceReference
"A specific and stability-indicating high-performance liquid chromatographic (HPLC) method has been developed for the analysis of calcium cyanamide in bulk material and dosage form."( Liquid chromatographic method for the determination of calcium cyanamide using pre-column derivatization.
Chen, S; Kucera, PJ; Ocampo, AP, 1991
)
0.72
" one hour before ethanol), caused increases of up to 23-fold in the hepatic acetaldehyde level, without influencing the cytosolic NAD+:NADH ratio in ethanol dosed rats, while significantly reducing the ethanol elimination rate by up to 44%, compared with controls."( The roles of the hepatocellular redox state and the hepatic acetaldehyde concentration in determining the ethanol elimination rate in fasted rats.
Chakraborty, J; Ryle, PR; Thomson, AD, 1985
)
0.27
" The effect of dosing rate on the plasma concentration of cyanamide at apparent steady-state showed non-linearity, indicating that clearance or first-pass metabolism of cyanamide during its absorption after intraperitoneal administration did not remain constant throughout the range of doses studied."( Inhibition of rat hepatic mitochondrial aldehyde dehydrogenase isozymes by repeated cyanamide administration: pharmacokinetic-pharmacodynamic relationships.
Bozal, J; Obach, R; Pruñonosa Piera, J; Sagristá, ML, 1993
)
0.75
"48 mmol/kg) followed by oral dosing with ME (2."( Methoxyacetaldehyde, an intermediate metabolite of 2-methoxyethanol, is immunosuppressive in the rat.
Riddle, MM; Smialowicz, RJ; Williams, WC, 1993
)
0.29
" Although nasal tissues express ALDH, the importance of this enzyme relative to delivered dosage rates at high-inspired concentrations is not well defined."( The effect of inhibition of aldehyde dehydrogenase on nasal uptake of inspired acetaldehyde.
Morris, JB; Stanek, JJ, 1999
)
0.3
" In acute studies, rats were dosed with saline (0."( Fatty acid profile in skeletal muscle of the rat in response to acute (2.5 hours) and prolonged (6 weeks) ethanol-dosage.
Adachi, J; Koll, M; Kudo, R; Nushida, H; Preedy, VR; Ueno, Y, 2003
)
0.32
" Previous reports on rats dosed acutely with ethanol (<24 h) have suggested that increased proto-oncogene expression (i."( Acute and chronic effects of alcohol exposure on skeletal muscle c-myc, p53, and Bcl-2 mRNA expression.
Hashimoto, K; Hirano, M; Koll, M; Martin, CR; Nakahara, T; Preedy, VR, 2003
)
0.32
" The concentration of EtOH and AcH in the striatal dialysate reached a peak at 30 min after EtOH dosing and then gradually decreased in the CY+EtOH group."( Failure of ethanol and acetaldehyde to alter in vivo norepinephrine release in the striatum and hippocampus of rats.
Ameno, K; Ameno, S; Ijiri, I; Jamal, M; Kubota, T; Kumihashi, M; Wang, W, 2004
)
0.32
" A significant decrease in ACh release was observed from 140 to 240 min after EtOH dosing in the EtOH (1 and 2 g/kg) groups, as compared to saline groups."( Inhibition of acetaldehyde metabolism decreases acetylcholine release in medial frontal cortex of freely moving rats.
Ameno, K; Ameno, S; Ijiri, I; Ikuo, U; Jamal, M; Kumihashi, M; Shinji, A; Wang, W, 2005
)
0.33
") of cyanamide (10 mg/kg, 60 min before ethanol dosing) with or without ethanol (1g/kg) for 5 consecutive days, and were sacrificed 60 min after the last dosing of ethanol."( Differential regulation of proopiomelanocortin (POMC) mRNA expression in hypothalamus and anterior pituitary following repeated cyanamide with ethanol administration.
Ameno, K; Harbuz, MS; Hishida, S; Ijiri, I; Kinoshita, H, 2005
)
1.05
" This study aimed to address (i) whether long-term alcohol feeding alters expression of heat shock proteins (HSPs) in male and female rats; (ii) the effect of immediate alcohol dosing with or without raised levels of endogenous acetaldehyde; and (iii) the effect of starvation."( Alcohol alters skeletal muscle heat shock protein gene expression in rats: these effects are moderated by sex, raised endogenous acetaldehyde, and starvation.
Broome, CS; Hirano, M; Hunter, R; Koll, M; Martin, CR; McArdle, A; Nakahara, T; Preedy, VR; Uchimura, H, 2006
)
0.33
" The results showed that EtOH and acetaldehyde decreased ChAT expression at 40 and 240 min after EtOH dosing in the brain."( Ethanol and acetaldehyde: in vivo quantitation and effects on cholinergic function in rat brain.
Ameno, K; Ijiri, I; Ikuo, U; Jamal, M; Kumihashi, M; Wang, W, 2007
)
0.34
" Ethanol (20 mM) reduced the potency of the PPARbeta ligand GW0742, evident by a rightward shift in the GW0742 dose-response curve, whereas for PPARalpha activation by GW7647, ethanol mediated its effects primarily through reducing efficacy as evidenced by a reduction in maximal response."( PPARalpha and PPARbeta are differentially affected by ethanol and the ethanol metabolite acetaldehyde in the MCF-7 breast cancer cell line.
Aung, CS; Cabot, PJ; Monteith, GR; Roberts-Thomson, SJ; Venkata, NG, 2008
)
0.35
" Current practices such as process sterilization or antibiotic dosage carry excess costs or encourage the development of antibiotic resistance."( Metabolic engineering of microbial competitive advantage for industrial fermentation processes.
Brevnova, EE; Consiglio, A; Greenhagen, E; Hamilton, M; Lam, FH; LaTouf, WG; MacEwen, K; Shaw, AJ; South, CR; Stephanopoulos, G; van Dijken, H, 2016
)
0.43
" A follow-up experiment tested ZS at six different rates (0-187 kg ha-1) but detected no significant dose-response on budbreak."( Budbreak patterns and phytohormone dynamics reveal different modes of action between hydrogen cyanamide- and defoliant-induced flower budbreak in blueberry under inadequate chilling conditions.
Agehara, S; Lin, SY, 2021
)
0.84
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
EC 1.2.1.3 [aldehyde dehydrogenase (NAD(+))] inhibitorAn EC 1.2.1.* (oxidoreductase acting on donor aldehyde/oxo group with NAD(+) or NADP(+) as acceptor) inhibitor that interferes with the action of aldehyde dehydrogenase (NAD(+)), EC 1.2.1.3.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
nitrileA compound having the structure RC#N; thus a C-substituted derivative of hydrocyanic acid, HC#N. In systematic nomenclature, the suffix nitrile denotes the triply bound #N atom, not the carbon atom attached to it.
one-carbon compoundAn organic molecular entity containing a single carbon atom (C1).
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (3)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency89.96460.003041.611522,387.1992AID1159552; AID1159555
thyroid hormone receptor beta isoform aHomo sapiens (human)Potency14.12540.010039.53711,122.0200AID588547
lamin isoform A-delta10Homo sapiens (human)Potency0.00090.891312.067628.1838AID1487
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (28)

Assay IDTitleYearJournalArticle
AID1296008Cytotoxic Profiling of Annotated Libraries Using Quantitative High-Throughput Screening2020SLAS discovery : advancing life sciences R & D, 01, Volume: 25, Issue:1
Cytotoxic Profiling of Annotated and Diverse Chemical Libraries Using Quantitative High-Throughput Screening.
AID1346986P-glycoprotein substrates identified in KB-3-1 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID1346987P-glycoprotein substrates identified in KB-8-5-11 adenocarcinoma cell line, qHTS therapeutic library screen2019Molecular pharmacology, 11, Volume: 96, Issue:5
A High-Throughput Screen of a Library of Therapeutics Identifies Cytotoxic Substrates of P-glycoprotein.
AID504749qHTS profiling for inhibitors of Plasmodium falciparum proliferation2011Science (New York, N.Y.), Aug-05, Volume: 333, Issue:6043
Chemical genomic profiling for antimalarial therapies, response signatures, and molecular targets.
AID170944Tested for effect on ethanol derived blood Ach levels in rats at 1.0 mmol/kg1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Acyl, N-protected alpha-aminoacyl, and peptidyl derivatives as prodrug forms of the alcohol deterrent agent cyanamide.
AID228964Nitrous oxide formed in the oxidation of 15NH2-labeled cyanamide by catalase/glucose-glucose oxidase using gas chromatography.1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Evidence for nitroxyl in the catalase-mediated bioactivation of the alcohol deterrent agent cyanamide.
AID1079937Severe hepatitis, defined as possibly life-threatening liver failure or through clinical observations. Value is number of references indexed. [column 'MASS' in source]
AID1079946Presence of at least one case with successful reintroduction. [column 'REINT' in source]
AID170945Tested for effect on ethanol derived blood Ach levels in rats at 1.0 mmol/kg1986Journal of medicinal chemistry, Oct, Volume: 29, Issue:10
Acyl, N-protected alpha-aminoacyl, and peptidyl derivatives as prodrug forms of the alcohol deterrent agent cyanamide.
AID1079931Moderate liver toxicity, defined via clinical-chemistry results: ALT or AST serum activity 6 times the normal upper limit (N) or alkaline phosphatase serum activity of 1.7 N. Value is number of references indexed. [column 'BIOL' in source]
AID1079943Malignant tumor, proven histopathologically. Value is number of references indexed. [column 'T.MAL' in source]
AID1079949Proposed mechanism(s) of liver damage. [column 'MEC' in source]
AID1079938Chronic liver disease either proven histopathologically, or through a chonic elevation of serum amino-transferase activity after 6 months. Value is number of references indexed. [column 'CHRON' in source]
AID1079936Choleostatic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is < 2 (see ACUTE). Value is number of references indexed. [column 'CHOLE' in source]
AID228966Nitrous oxide formed in the oxidation of unlabeled cyanamide by catalase/glucose-glucose oxidase using gas chromatography.1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Evidence for nitroxyl in the catalase-mediated bioactivation of the alcohol deterrent agent cyanamide.
AID1079945Animal toxicity known. [column 'TOXIC' in source]
AID1079932Highest frequency of moderate liver toxicity observed during clinical trials, expressed as a percentage. [column '% BIOL' in source]
AID1079933Acute liver toxicity defined via clinical observations and clear clinical-chemistry results: serum ALT or AST activity > 6 N or serum alkaline phosphatases activity > 1.7 N. This category includes cytolytic, choleostatic and mixed liver toxicity. Value is
AID228965Nitrous oxide formed in the oxidation of U-labeled [N15]-cyanamide by catalase/glucose-glucose oxidase using gas chromatography1990Journal of medicinal chemistry, Dec, Volume: 33, Issue:12
Evidence for nitroxyl in the catalase-mediated bioactivation of the alcohol deterrent agent cyanamide.
AID1079944Benign tumor, proven histopathologically. Value is number of references indexed. [column 'T.BEN' in source]
AID1079940Granulomatous liver disease, proven histopathologically. Value is number of references indexed. [column 'GRAN' in source]
AID1079941Liver damage due to vascular disease: peliosis hepatitis, hepatic veno-occlusive disease, Budd-Chiari syndrome. Value is number of references indexed. [column 'VASC' in source]
AID1079935Cytolytic liver toxicity, either proven histopathologically or where the ratio of maximal ALT or AST activity above normal to that of Alkaline Phosphatase is > 5 (see ACUTE). Value is number of references indexed. [column 'CYTOL' in source]
AID1079947Comments (NB not yet translated). [column 'COMMENTAIRES' in source]
AID1079948Times to onset, minimal and maximal, observed in the indexed observations. [column 'DELAI' in source]
AID1079942Steatosis, proven histopathologically. Value is number of references indexed. [column 'STEAT' in source]
AID1079939Cirrhosis, proven histopathologically. Value is number of references indexed. [column 'CIRRH' in source]
AID1079934Highest frequency of acute liver toxicity observed during clinical trials, expressed as a percentage. [column '% AIGUE' in source]
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (555)

TimeframeStudies, This Drug (%)All Drugs %
pre-1990208 (37.48)18.7374
1990's97 (17.48)18.2507
2000's122 (21.98)29.6817
2010's97 (17.48)24.3611
2020's31 (5.59)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 69.78

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index69.78 (24.57)
Research Supply Index6.43 (2.92)
Research Growth Index4.48 (4.65)
Search Engine Demand Index123.73 (26.88)
Search Engine Supply Index2.03 (0.95)

This Compound (69.78)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials16 (2.66%)5.53%
Reviews22 (3.65%)6.00%
Case Studies40 (6.64%)4.05%
Observational0 (0.00%)0.25%
Other524 (87.04%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]